| |
| |
|
| Insider
Information: |
Glenn Gregory M |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,339 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,339 |
|
|
| Total
Value |
$6,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2023-03-10 |
18,339 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-16 |
4 |
AS |
$223.26 |
$435,750 |
D/D |
(1,866) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-16 |
4 |
OE |
$27.60 |
$75,826 |
D/D |
1,866 |
5,927 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
D |
$230.34 |
$16,584 |
D/D |
(72) |
6,743 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
AS |
$227.74 |
$974,740 |
D/D |
(4,167) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
OE |
$5.95 |
$41,180 |
D/D |
6,921 |
6,815 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
D |
$230.34 |
$298,521 |
D/D |
(1,296) |
5,447 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-31 |
4 |
AS |
$234.64 |
$332,463 |
D/D |
(1,386) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-15 |
4 |
OE |
$27.60 |
$44,832 |
D/D |
1,183 |
5,244 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-15 |
4 |
AS |
$224.59 |
$271,304 |
D/D |
(1,183) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
OE |
$5.95 |
$20,587 |
D/D |
3,460 |
5,438 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
D |
$231.04 |
$8,317 |
D/D |
(36) |
5,402 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
AS |
$228.12 |
$488,315 |
D/D |
(2,083) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-27 |
4 |
D |
$231.04 |
$149,714 |
D/D |
(648) |
4,754 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-09-30 |
4 |
AS |
$202.84 |
$143,622 |
D/D |
(693) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-05 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-05 |
4 |
AS |
$170.80 |
$1,438,895 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-12 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-12 |
4 |
AS |
$161.58 |
$1,346,218 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-15 |
4 |
AS |
$170.00 |
$201,110 |
D/D |
(1,183) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-15 |
4 |
OE |
$27.60 |
$44,832 |
D/D |
1,183 |
5,244 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-19 |
4 |
OE |
$19.08 |
$157,410 |
D/D |
8,250 |
12,311 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-19 |
4 |
AS |
$161.00 |
$1,362,427 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-26 |
4 |
AS |
$130.93 |
$1,371,667 |
D/D |
(10,334) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-26 |
4 |
OE |
$5.95 |
$178,009 |
D/D |
11,712 |
5,439 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-26 |
4 |
D |
$134.99 |
$8,234 |
D/D |
(61) |
5,378 |
0 |
- |
|
128 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
